Etanercept in combination with narrowband ultraviolet light B for the treatment of moderate to severe plaque psoriasis

被引：0
|
作者：
Moore, Angela Yen [1 ]
Richardson, Blakely S. [1 ]
机构：
[1] Arlington Ctr Dermatol, Arlington, TX USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2010年 / 62卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB136 / AB136
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF ETANERCEPT AND EFALIZUMAB IN THE MANAGEMENT OF MODERATE AND SEVERE PLAQUE PSORIASIS
    Ortonne, J. P.
    Feneron, D.
    Daures, J. P.
    Ollivier, A. L.
    Thiriet, C.
    Maurel, F.
    Le Pen, C.
    VALUE IN HEALTH, 2008, 11 (06) : A617 - A617
  • [22] Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Girish A.
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, John
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 340 - 346
  • [23] A PHASE 3, MULTICENTER, RANDOMIZED STUDY COMPARING USTEKINUMAB AND ETANERCEPT FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
    Griffiths, C.
    Strober, B.
    van der Kerkhof, P. C. M.
    Ho, V
    Guzzo, C.
    Yeilding, N.
    Fidelus-Gort, R.
    Zhou, B.
    Xia, K.
    Menter, A.
    ACTA DERMATO-VENEREOLOGICA, 2009, 89 (05) : 584 - 585
  • [24] Clinical and genetic predictors of treatment response to narrowband ultraviolet B radiation for chronic plaque psoriasis
    Ryan, C.
    Collins, P.
    Kirby, B.
    Rogers, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 : 8 - 8
  • [25] Combination therapy with PUVA and etanercept in the treatment of severe psoriasis
    Woodson, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P179 - P179
  • [26] A phase III, multicenter, randomized study comparing ustekinumab and etanercept for the treatment of moderate to severe plaque psoriasis
    Griffiths, C.
    Menter, A.
    Strober, B.
    Fidelus-Gort, R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB166 - AB166
  • [27] Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis
    Hutmacher, Matthew M.
    Nestorov, Ivan
    Ludden, Tom
    Zitnik, Ralph
    Banfield, Christopher
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02): : 238 - 248
  • [28] Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis
    Romani, J.
    Caixas, A.
    Carrascosa, J. M.
    Ribera, M.
    Rigla, M.
    Luelmo, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (06) : 1237 - 1244
  • [29] Cost-effectiveness analysis between home narrowband ultraviolet B phototherapy and biologic drugs in the treatment of moderate to severe psoriasis
    Vano-Galvan, Sergio
    Jaen, Pedro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB189 - AB189
  • [30] COST EFFECTIVENESS OF TREATMENT WITH ETANERCEPT OR USTEKINUMAB FOR MODERATE TO SEVERE PSORIASIS
    Villacorta, R.
    Hay, J.
    Messali, A.
    VALUE IN HEALTH, 2012, 15 (04) : A103 - A103
12345